BioStock: Cereno signs licensing deal with University of Michigan

Cereno Scientific continues to move forward with its plan to take two preclinical candidates for cardiovascular disease treatment into clinical development. This week, Cereno signed a licensing agreement with the University of Michigan that provides Cereno with exclusive rights to candidate CS585 for development and commercialisation.

Read the article at biostock.se:

Cereno signs licensing deal with University of Michigan - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/